Voyager Therapeutics Inc VYGR
News
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results
Voyager Therapeutics Announces Second Quarter 2024 Conference Call and Webcast
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Voyager Therapeutics Shares Leap Premarket on Novartis Collaboration
Voyager Therapeutics shares soar 32% on news of deal with Novartis that includes up to $1.2 billion in milestone payments